Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

8.95
Delayed Data
As of Mar 22
 -0.05 / -0.56%
Today’s Change
7.75
Today|||52-Week Range
37.20
-32.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues511.5M596.0M860.5M824.4M
 
 
 
 
 
Cost of Goods Sold269.2M246.5M439.4M371.5M
 
 
 
 
 
Depreciation And Amortization36.0M34.0M68.6M88.3M
 
 
 
 
 
 
Operating ExpensesGross Income206.3M315.6M352.4M364.6M
 
 
 
 
 
General Expenses182.2M218.5M265.0M319.5M
 
 
 
 
 
Research And Development68.1M79.1M77.0M80.5M
 
 
 
 
 
Total Operating Expenses487.3M499.0M773.0M779.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income24.2M97.0M87.4M45.1M
 
 
 
 
 
Extraordinary Credit88.5M0.00--0.00
 
 
Extraordinary Charge-14.0M-8.2M-47.8M-580.6M
 
 
 
 
 
Interest Expense On Debt419.0K0.0027.3M41.4M
 
 
 
 
Other Expenses47.4M270.0K45.9M-464.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income146.9M90.6M59.4M-576.3M
 
 
 
 
 
Income Taxes-45.7M-33.2M-20.4M-104.3M
 
 
 
 
 
Net Income101.3M57.4M39.0M-472.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS66.9M68.2M69.6M71.1M
 
 
 
 
 
Shares To Calculate EPS Diluted68.7M70.5M72.0M71.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.47$0.81$0.54-$6.63
 
 
 
 
 
EPS Diluted$1.47$0.81$0.54-$6.63